13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 59 holding rows worth $99,148,000.
- Accession
- 0001389933-14-000012
- Filer
- CIK 1389933
- Filed
- 2014-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2014
A holdings report, 59 entries on the cover page, a total value of $99,148,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $99,148,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PHARMACYCLICS INC | 716933106 | COM | 110,928 | $13,026,000 | thousands by filing date | |
| DISCOVERY LABORATORIES INC N | 254668403 | COM NEW | 5,698,739 | $10,486,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 598,883 | $8,816,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 384,154 | $5,044,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 109,418 | $4,032,000 | thousands by filing date | |
| AUSPEX PHARMACE | 05211J102 | Common Stock | 152,002 | $3,902,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 263,541 | $3,344,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 675,650 | $3,311,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 384,794 | $3,205,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,374,975 | $3,190,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 1,288,440 | $3,118,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 145,342 | $3,007,000 | thousands by filing date | |
| INSULET CORP | 45784PAD3 | NOTE 2.000% 6/1 | 2,407,000 | $2,675,000 | thousands by filing date | principal |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 60,054 | $2,120,000 | thousands by filing date | |
| THRESHOLD PHARMACEUTICAL INC | 885807206 | COM NEW | 555,965 | $2,007,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 36,900 | $1,674,000 | thousands by filing date | |
| CARDICA INC | 14141R101 | COM | 1,486,004 | $1,590,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 235,645 | $1,581,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 240,190 | $1,292,000 | thousands by filing date | |
| UROPLASTY INC | 917277204 | COM NEW | 486,062 | $1,215,000 | thousands by filing date | |
| NUVASIVE INC | 670704AC9 | CORPORATE OBLIG | 1,000,000 | $1,146,000 | thousands by filing date | principal |
| SPECTRANETICS CORP | 84760C107 | COM | 42,162 | $1,120,000 | thousands by filing date | |
| VENAXIS INC | 92262A107 | COM | 658,000 | $1,092,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 66,141 | $1,036,000 | thousands by filing date | |
| GALMED PHARMACEUTICALS LTD | M47238106 | SHS | 116,987 | $1,006,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 9,400 | $1,002,000 | thousands by filing date | |
| ENCISION INC | 29254Q104 | COM | 1,062,500 | $983,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 90,947 | $911,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 25,000 | $897,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 88,694 | $896,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 120,000 | $756,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 76,400 | $747,000 | thousands by filing date | |
| EXACTECH INC | 30064E109 | COM | 31,636 | $724,000 | thousands by filing date | |
| AASTROM BIOSCIENCES INC | 00253U404 | COM PAR$ | 238,900 | $681,000 | thousands by filing date | |
| CYTRX CORP | 232828509 | COM PAR $.001 | 225,000 | $572,000 | thousands by filing date | |
| Ampio Pharmaceuticals | 03209T109 | COM | 150,000 | $530,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 75,000 | $525,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 2,000 | $473,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 214,972 | $413,000 | thousands by filing date | |
| RTI BIOLOGICS INC | 74975N105 | COM | 85,918 | $411,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 75,930 | $387,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 17,500 | $372,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 50,000 | $370,000 | thousands by filing date | |
| LPATH INC-CLASS A | 548910306 | CMN | 102,798 | $362,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 133,972 | $339,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 32,000 | $296,000 | thousands by filing date | |
| CELSUS THERAPEUTICS PLC | 15119A202 | COM | 43,900 | $268,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 26,000 | $259,000 | thousands by filing date | |
| LUMENIS LTD | M6778Q121 | SHS CL B | 29,018 | $259,000 | thousands by filing date | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 116,279 | $244,000 | thousands by filing date | |
| INTELLIPHARMACEUTICS INTERNA | 458173101 | CMN | 72,787 | $219,000 | thousands by filing date | |
| CURIS INC | 231269101 | COM | 150,000 | $212,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 100,000 | $208,000 | thousands by filing date | |
| CHEMBIO DIAGNOSTICS | 163572209 | COM | 55,202 | $205,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 25,000 | $171,000 | thousands by filing date | |
| CYNAPSUS THERAPEUTICS INC | 23257Y156 | COM | 280,769 | $149,000 | thousands by filing date | |
| INSPIREMD INC | 45779A309 | COM | 63,700 | $140,000 | thousands by filing date | |
| GLOBEIMMUNE INC | 37957B100 | COM | 10,745 | $74,000 | thousands by filing date | |
| RETRACTABLE TECHNOLOGIES INC | 76129W105 | COM | 20,000 | $58,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-14-000012 | this filing | 2014-11-14 | acceptance time not in the bulk data set |